Ht-Logo-gigapixel-icon
Tuesday, November 5, 2024
Canada’s Politics and Government News Source Since 1989
Tuesday, November 5, 2024 | Latest Paper

David Macdonald and Toby Sanger

David Macdonald is senior economist with the Canadian Centre for Policy Alternatives and Toby Sanger is executive director of Canadians for Tax Fairness. They published A Prescription for Savings: Federal Revenue Options for Pharmacare and Their Distributional Impacts on Households, Businesses and governments in December.

Prescription for savings: how the feds can make pharmacare work for households and employers

Canada's federal Health Minister Ginette Petitpas-Taylor. The best option for households is if a corporate income tax pays for pharmacare. Then middle-class households save over $600 a year on average, although employers likely wouldn’t be so happy seeing their net costs go up far more than their savings from lower drug insurance premiums. The Hill Times photograph by Andrew Meade
Canada's federal Health Minister Ginette Petitpas-Taylor. The best option for households is if a corporate income tax pays for pharmacare. Then middle-class households save over $600 a year on average, although employers likely wouldn’t be so happy seeing their net costs go up far more than their savings from lower drug insurance premiums. The Hill Times photograph by Andrew Meade
Canada's federal Health Minister Ginette Petitpas-Taylor. The best option for households is if a corporate income tax pays for pharmacare. Then middle-class households save over $600 a year on average, although employers likely wouldn’t be so happy seeing their net costs go up far more than their savings from lower drug insurance premiums. The Hill Times photograph by Andrew Meade
Canada's federal Health Minister Ginette Petitpas-Taylor. The best option for households is if a corporate income tax pays for pharmacare. Then middle-class households save over $600 a year on average, although employers likely wouldn’t be so happy seeing their net costs go up far more than their savings from lower drug insurance premiums. The Hill Times photograph by Andrew Meade